Amgen (AMGN) Operating Income (2009 - 2026)

Amgen has reported Operating Income for 18 years, with the latest figure at $2.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Operating Income rose 126.32% year-over-year to $2.7 billion; the trailing twelve-month figure through Mar 2026 stood at $10.6 billion (up 41.95% YoY), and the FY2025 full-year result was $9.1 billion, up 25.1% from the prior year.
• Operating Income for Q1 2026 stood at $2.7 billion, down from $2.7 billion in the prior quarter.
• The five-year high for Operating Income was $2.7 billion in Q4 2025, with the low at $991.0 million in Q1 2024.
• Average Operating Income over 5 years is $2.1 billion, with a median of $2.2 billion recorded in 2022.
• Year-over-year, Operating Income soared 162.8% in 2022 and tumbled 48.41% in 2024.
• Tracing AMGN's Operating Income over 5 years: stood at $2.2 billion in 2022, then plunged by 43.0% to $1.3 billion in 2023, then jumped by 81.83% to $2.3 billion in 2024, then gained by 17.7% to $2.7 billion in 2025, then decreased by 1.99% to $2.7 billion in 2026.
• The last three Operating Income figures came in at $2.7 billion (Q1 2026), $2.7 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.

Peer Comparison